Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Perner

Showing results (161-170 of 283) with videos related to

Pageof 29
Sort By:
The American Journal of Surgical Pathology|February 15, 2014
GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs"Hanno Matthaei, Jian Wu, Marco Dal Molin, et al.
Cancer Research|February 18, 2017
Prominent Oncogenic Roles of EVI1 in Breast CarcinomaHui Wang, Thorsten Schaefer, Martina Konantz, et al.
Virchows Archiv : an International Journal of Pathology|July 7, 2012
ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancerVeit J Scheble, Gregor Scharf, Martin Braun, et al.
Blood|July 23, 2013
Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosisWen-Ming Peng, Laura Maintz, Jean-Pierre Allam, et al.
Oncotarget|April 16, 2016
MERTK as a novel therapeutic target in head and neck cancerAnne von Mässenhausen, Christine Sanders, Britta Thewes, et al.
Frontiers in Medicine|October 17, 2017
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade GroupsAnne Offermann, Silke Hohensteiner, Christiane Kuempers, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2023
Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinomaIsabel Porth, Daniela Hirsch, Yonca Ceribas, et al.
Nature Communications|April 20, 2018
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockadeVictoria Klepsch, Natascha Hermann-Kleiter, Patricia Do-Dinh, et al.
Plos One|January 30, 2014
Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanomaDiana Meckbach, Jürgen Bauer, Annette Pflugfelder, et al.
Neoplasia (New York, N.Y.)|April 3, 2007
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old modelKirsten D Mertz, Sunita R Setlur, Saravana M Dhanasekaran, et al.
Pageof 29

Showing results (161-170 of 283) with videos related to

Sort By:
Pageof 29
The American Journal of Surgical Pathology|February 15, 2014
GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs"Hanno Matthaei, Jian Wu, Marco Dal Molin, et al.
Cancer Research|February 18, 2017
Prominent Oncogenic Roles of EVI1 in Breast CarcinomaHui Wang, Thorsten Schaefer, Martina Konantz, et al.
Virchows Archiv : an International Journal of Pathology|July 7, 2012
ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancerVeit J Scheble, Gregor Scharf, Martin Braun, et al.
Blood|July 23, 2013
Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosisWen-Ming Peng, Laura Maintz, Jean-Pierre Allam, et al.
Oncotarget|April 16, 2016
MERTK as a novel therapeutic target in head and neck cancerAnne von Mässenhausen, Christine Sanders, Britta Thewes, et al.
Frontiers in Medicine|October 17, 2017
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade GroupsAnne Offermann, Silke Hohensteiner, Christiane Kuempers, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2023
Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinomaIsabel Porth, Daniela Hirsch, Yonca Ceribas, et al.
Nature Communications|April 20, 2018
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockadeVictoria Klepsch, Natascha Hermann-Kleiter, Patricia Do-Dinh, et al.
Plos One|January 30, 2014
Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanomaDiana Meckbach, Jürgen Bauer, Annette Pflugfelder, et al.
Neoplasia (New York, N.Y.)|April 3, 2007
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old modelKirsten D Mertz, Sunita R Setlur, Saravana M Dhanasekaran, et al.
Pageof 29